Bora CDMO Bora CDMO

X

Find Ensitrelvir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Ensitrelvir
Also known as: 2647530-73-0, Ensitrelvir [inn], Px665raa3h, S-217622, 1,3,5-triazine-2,4(1h,3h)-dione, 6-((6-chloro-2-methyl-2h-indazol-5-yl)imino)dihydro-3-((1-methyl-1h-1,2,4-triazol-3-yl)methyl)-1-((2,4,5-trifluorophenyl)methyl)-, (6e)-, 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione
Molecular Formula
C22H17ClF3N9O2
Molecular Weight
531.9  g/mol
InChI Key
QMPBBNUOBOFBFS-UHFFFAOYSA-N
FDA UNII
PX665RAA3H

1 2D Structure

Ensitrelvir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione
2.1.2 InChI
InChI=1S/C22H17ClF3N9O2/c1-32-7-12-4-18(13(23)5-17(12)30-32)28-20-29-21(36)35(9-19-27-10-33(2)31-19)22(37)34(20)8-11-3-15(25)16(26)6-14(11)24/h3-7,10H,8-9H2,1-2H3,(H,28,29,36)
2.1.3 InChI Key
QMPBBNUOBOFBFS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1C=C2C=C(C(=CC2=N1)Cl)NC3=NC(=O)N(C(=O)N3CC4=CC(=C(C=C4F)F)F)CC5=NN(C=N5)C
2.2 Other Identifiers
2.2.1 UNII
PX665RAA3H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (6e)-6-((6-chloro-2-methyl-2h-indazol-5-yl)imino)dihydro-3-((1-methyl-1h-1,2,4-triazol-3-yl)methyl)-1-((2,4,5-trifluorophenyl)methyl)-1,3,5-triazine-2,4(1h,3h)-dione

2. S-217622

3. S217622

2.3.2 Depositor-Supplied Synonyms

1. 2647530-73-0

2. Ensitrelvir [inn]

3. Px665raa3h

4. S-217622

5. 1,3,5-triazine-2,4(1h,3h)-dione, 6-((6-chloro-2-methyl-2h-indazol-5-yl)imino)dihydro-3-((1-methyl-1h-1,2,4-triazol-3-yl)methyl)-1-((2,4,5-trifluorophenyl)methyl)-, (6e)-

6. 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione

7. 7yy

8. Unii-px665raa3h

9. Ensitrelvir (s-217622)

10. Gtpl11871

11. Bdbm513874

12. Glxc-25352

13. Ex-a5760

14. At32299

15. Compound 3 [pmid: 35352927]

16. Hy-143216

17. Compound I-0006 [wo2022138987]

18. Cs-0374996

19. S217622

20. Biorxiv20220126.477782, S-217622

21. (6e)-6-[(6-chloro-2-methyl-2h-indazol-5-yl)imino]-3-[(1-methyl-1h-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazinane-2,4-dione

22. (e)-6-((6-chloro-2-methyl-2h-indazol-5-yl)imino)-3-((1-methyl-1h-1,2,4-triazol-3-yl)methyl)-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione

2.4 Create Date
2022-02-09
3 Chemical and Physical Properties
Molecular Weight 531.9 g/mol
Molecular Formula C22H17ClF3N9O2
XLogP32.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass531.1145830 g/mol
Monoisotopic Mass531.1145830 g/mol
Topological Polar Surface Area114 Ų
Heavy Atom Count37
Formal Charge0
Complexity919
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY